Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
The Royal Bournemouth Hospital |
---|---|
Information provided by: | The Royal Bournemouth Hospital |
ClinicalTrials.gov Identifier: | NCT00135070 |
Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.
Condition | Intervention | Phase |
---|---|---|
Diabetes Mellitus, Type 2 |
Drug: Detemir |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia |
Enrollment: | 41 |
Study Start Date: | July 2005 |
Study Completion Date: | June 2006 |
This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar > than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom, Dorset | |
The Royal Bournemouth Hospital | |
Bournemouth, Dorset, United Kingdom, BH7 7DW |
Principal Investigator: | David Kerr, Doctor | The Royal Bournemouth Hospital |
Study ID Numbers: | H.P.I.1 |
Study First Received: | August 23, 2005 |
Last Updated: | April 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00135070 |
Health Authority: | United Kingdom: Research Ethics Committee |
Diabetes Mellitus |
Metabolic Diseases Hyperglycemia Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Insulin |